$1.57
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

SINTX Technologies, Inc. is a ceramics company, which engages in the development and commercialization of silicon nitride for medical and non-medical applications. The company is headquartered in Salt Lake City, Utah and currently employs 32 full-time employees. The company went IPO on 2014-02-11. The company is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. The company has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. The company manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Country

US

CEO

Mr. Eric Olson

IPO date

2014

Employees

32

ISIN

US8293927039

Website

sintx.com

Key stats

Open

$1.58

Volume

25.46K

Market cap

$10.33M

Prev. close

$1.55

Impl / hst vl

-

Open interest

$0.00

$1.50

Day’s Range

$1.58

$1.40

52W Range

$4.14

Valuation

27
Valuation score
Overvalued
P/E
-
P/S
11.17
P/B
12.72
Current ratio
-
Debt / Equity
0.12
ROE
-
Gross margin
-
Income growth
28.75%
FCF growth
14.13

Analysts estimates

Consensus rating
Buy

The average rating from top 6 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$9.52
The top 5 analysts forecasts that 12-month price may increase by 506.37%, with a low of $6.06 and a high of $12.60
$6.06
Low
$9.52
Avg
$12.60
High
Current price

Earnings

Q2 ‘26 revenue
$452.00K
Q2 ‘26 net income
-$3.63M
Revenue
Net income
Previous EPS
-$0.70
Estimate EPS
-$0.69
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply